Tryptamine Therapeutics Limited Share Price
Equities
TYP
AU0000331993
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.023 AUD | -.--% | -.--% | -.--% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 30.5M 22.36M 33.67M 1.76B |
---|---|---|---|---|---|
Net income 2024 * | -5M -3.67M -5.52M -288M | Net income 2025 * | -5M -3.67M -5.52M -288M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.31% |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 0.023 | -.--% | 3,375,302 |
30/05/24 | 0.023 | -11.54% | 6,208,662 |
Delayed Quote Australian S.E., May 31, 2024 at 07:10 am
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 22.36M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- TYP Stock